NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.65% | 2,008.30% | 105.39% | 0.68% | 234.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.65% | 2,008.30% | 105.39% | 0.68% | 234.92% |
| Cost of Revenue | 7.74% | 87.20% | 12.95% | -36.97% | 14.80% |
| Gross Profit | -76.40% | 450.67% | 70.67% | 128.11% | 162.01% |
| SG&A Expenses | -7.73% | -3.39% | -13.93% | -3.12% | -5.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 194.30% | 130.24% | -1.02% | -4.62% | -64.22% |
| Operating Income | -199.77% | 51.32% | 32.47% | 7.14% | 150.47% |
| Income Before Tax | -180.54% | 51.67% | 45.77% | 20.47% | 153.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -180.54% | 51.67% | 45.77% | 20.47% | 153.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -180.54% | 51.67% | 45.77% | 20.47% | 153.37% |
| EBIT | -199.77% | 51.32% | 32.47% | 7.14% | 150.47% |
| EBITDA | -192.43% | 52.53% | 33.35% | 7.46% | 153.31% |
| EPS Basic | -149.40% | 71.26% | 69.47% | 33.76% | 141.54% |
| Normalized Basic EPS | -172.79% | 90.74% | 62.97% | 22.35% | 132.49% |
| EPS Diluted | -151.81% | 71.26% | 69.47% | 33.76% | 141.36% |
| Normalized Diluted EPS | -172.79% | 90.74% | 62.97% | 22.35% | 132.49% |
| Average Basic Shares Outstanding | 63.21% | 67.93% | 77.70% | 20.07% | 28.51% |
| Average Diluted Shares Outstanding | 62.99% | 67.93% | 77.70% | 20.07% | 28.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |